Microorganisms and their interaction with the immune system

Journal of Leukocyte Biology

Volumn 62, Issue 4, 1997, Pages 415-429

  Kotwal, Girish J ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Macrophage; Proteins; Systemic immune response; T cells

Indexed keywords

CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN;

APOPTOSIS; AUTOIMMUNITY; BACTERIUM; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; HOST RESISTANCE; IMMUNE DEFICIENCY; IMMUNE SYSTEM; MICROORGANISM; NONHUMAN; OPPORTUNISTIC INFECTION; PARASITE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS;

EID: 0030727442     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.62.4.415     Document Type: Review

References (90)

1. Kotwal, G. J., McKenzie, R., Isaacs, S. N., Hugin, A. W., Frank, M. M., Moss, B. (1990) Viral encoded molecules for evasion of host defense mechanisms. In Defense Molecules (J. J. Marchalonis and C. L. Reinisch, eds.), New York: Wiley-Liss, 149-160.
2. Borst, P., Cross, G. A. M. (1982) Molecular basis for trypanosome antigenic variation. Cell 29, 291-303.
3. Ahmed, R., Morrison, L. A., Knipe, D. M. (1996) Persistence of viruses. In Fundamental Virology (B. N. Fields, P. M. Howley, and D. M. Knipe, eds.), New York: Lippincott-Raven, 207-237.
4. Brown, K. N. (1993) Antigenic diversity, antigenic variation and merozoite surface protein 1. Parasitologia 35, 13-15.
5. Mendis, K. N., David, P. H., Carter, R. (1991) Antigenic polymorphism in malaria: is it an important mechanism for immune evasion. Immunol. Today 12, A34-A37.
6. Kotwal, G. J., Moss, B. (1988) Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335, 176-178.
7. Kotwal, G. J., Isaacs, S. N., McKenzie, R., Frank, M. M., Moss, B. (1990) Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250, 827-830.
8. Kotwal, G. J. (1996) The great escape: Immune evasion by pathogens. Immunologist 4/5, 157-164.
9. Kotwal, G. J. (1994) Purification of virokines using ultrafiltration. Am. Biotech. Lab. 12, 76-77.
10. Miller, C. G., Shchelkunov, S. N., Kotwal, G. J. (1996) The cowpox virus homolog of the vaccinia virus complement control protein is an inflammation modulatory protein (IMP). Virology 229, 126-133.
11. Alcami, A., Smith, G. L. (1995) Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunol. Today 16, 474-478.
12. Upton, C., Macen, J. L., Schreiber, M., McFadden, G. (1991) Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184, 370-382.
13. Reid, K. B. M. (1995) The complement system: A major effector mechanism in humoral immunity. Immunologist 3, 206-211.
14. Buller, R. M. L., Palumbo, G. J. (1991) Poxvirus pathogenesis. Microbiol. Rev. 55, 80-122.
15. Miller, C. G., Justus, D. E., Jayaraman, S., Kotwal, G. J. (1995) Severe and prolonged inflammatory response to localized cowpox virus infection in footpads of C5-Deficient mice: Investigation of the role of host complement in poxvirus pathogenesis. Cell. Immunol. 162, 326-332.
16. Ray, C. A., Black, R. A., Kronheim, S. R., Greenstreet, T. A., Sleath, P. R., Salvesen, G. S., Pickup, D. J. (1992) Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 69, 597-694.
17. Kotwal, G. J., Moss, B. (1989) Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily. J. Virol. 63, 600-696.
18. Isaacs, S. N., Kotwal, G. J., Moss, B. (1992) Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA 89, 628-632.
19. Kotwal, G. J., Hugin, A. W., Moss, B. (1989) Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein. Virology 282, 688-698.
20. Graham, K. A., Lalani, A. S., Macen, J. L., Ness, T. L., Barry, M., Liu, L-Y. Lucas, A., Clark-Lewis, I., Moyer, R. W., McFadden, G. (1997) The T1/35 kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissue. Virology 229, 12-24.
21. McKenzie, R., Kotwal, G. J., Moss, B., Hammer, C. H., Frank, M. M. (1992) Regulation of complement activity by vaccinia virus complement-control protein. J. Infect. Dis. 166, 1245-1250.
22. Weisman, H. F., Bartow, T. Leppo, M. K., Marsh, H. C., Jr., Carson, G. R., Concino, M. F., Boyle, M. P., Roux, K. H., Weisfeldt, M. L., Fearon, D. T. (1990) Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249, 146-151.
23. Friedman, H. M., Wang, L., Fishman, N. O., Lambris, J. D., Eisenberg, R. J., Cohen, G. H., Lubinski, J. (1996) Immune evasion properties of Herpes Simplex virus type 1 glycoprotein gC. J. Virol. 70, 4253-4260.
24. Rother, R. P., Rollins, S. A., Fodor, W. L., Albrecht, J. C. Setter, E., Fleckenstein, B., Squinto, S. P. (1994) Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of Herpesvirus Saimiri. J. Virol. 68, 730-737.
25. Esparza, L. Becherer, J. D., Alsenz, J., De La Hera, A., Lao, Z., Tsoukas, C. D., Lambris, J. D. (1991) Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21). Eur. J. Immunol. 21, 2829-2837.
26. Ebenbichler, C. F., Thielens, N. M., Vornhagen, R., Barschang, P., Arlaud, G. J., Dierich, M. P. (1991) Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J. Exp. Med. 174, 1417.
27. Marschang, P., Sodroski, J., Wurzner, R., Dierich, M. P. (1995) Decayaccelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Eur. J. Immunol. 25, 285-290.
28. Horstmann, R. D., Sievertsen, H. J., Knoblock, J., Fischetti, V. A. (1988) Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc. Natl. Acad. Sci. USA 85, 1657-1661.
29. Fishelson, Z. (1994) Complement-related proteins in pathogenic organisms. Springer Semin. Immunopathol. 15, 345-368.
30. Stemmer, F., Loos, M. (1985) Evidence for direct binding of the first component of complement, C1, to outer membrane proteins from Salmonella minnesota. Curr. Top. Microbiol. Immunol. 121, 73-84.
31. Pramoonjago, P., Kaneko, M., Kinoshita, T., Ohtsubo, E., Takeda, J., Hong, K., Inagi, R., Inoue, K. (1984) Role of TraT protein, an anticomplementary protein produced in Escherichia coli by R100 factor, in serum resistance. J. Immunol. 148, 827-836.
32. Seifert, H. S., Wright, C. J., Jerse, A. E., Cohen, M. S., Cannon, J. G. (1994) Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J. Clin. Invest. 93, 2744-2749.
33. Heffernan, E. J., Harwood, J., Fierer, J., Guiney, D. (1992) The Salmonella typhimurium virulence plasmid complement resistance gene rck is homologous to a family of virulence-related outer membrane protein genes, including pagC and ail. J. Bacteriol. 174, 84-91.
34. Pilz, D., Vocke, T., Heesemann, J., Brade, V. (1992) Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica Serotype 03. Infect. Immun. 60, 189-195.
35. Jarvis, G. A. (1995) Recognition and control of neisserial infection by antibody and complement. Trends Microbiol. 3, 198-201.
36. Eigentler, A., Schulz, T. F., Larcher, C., Breitwieser, E. M., Myones, B. L., Petzer, A. L., Dierich, M. P. (1989) C3bi binding protein of Candida albicans: temperature-dependent expression and relationship to human complement receptor type 3. Infect. Immun. 57, 616-622.
37. Hostetter, M. K., Lorenz, J. S., Preus, L., Kendrick, K. E. (1990) The iC3b receptor on Candida albicans: subcellular localization and modulation of receptor expression by glucose. J. Infect. Dis. 161, 761-768.
38. Fukayama, M., Wadsworth, E., Calderone, R. (1992) Expression of the C3d-binding protein (CR2) from Candida albicans during experimental candidiasis as measured by lymphoblastogenesis. Infect. Immun. 60, 8-12.
39. Saxena, A., Calderone, R. (1990) Purification and characterization of the extracellular C3d-binding protein of Candida albicans. Infect. Immun. 58, 309-314.
40. Morgan, B. P., Meri, S. (1994) Membrane proteins that protect against complement lysis. Springer Semin. Immunopathol. 15, 369-396.
41. Fuhrman, S. A., Joiner, K. A. (1989) Toxoplasma gondii: mechanism of resistance to complement-mediated killing. J. Immunol. 142, 940-947.
42. Riley, E. M., Williamson, K. C., Greenwood, B. M., Kaslow, D. C. (1995) Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein, Pfs230. Parasite Immunol. 17, 11-19.
43. Modha, J., Doenhoff, M. J. (1994) Schistosoma mansoni host-parasite relationship: interaction of contrapsin with adult worms. Parasitology 109, 487-495.
44. Jokiranta, T. S., Jokipii, L., Meri, S. (1995) Complement resistance of parasites. Scand. J. Immunol. 42, 9-20.
45. Toney, D. M., Marciano-Cabral, F. (1994) Membrane vesiculation of Naegleria fowleri amoebae as a mechanism for resisting complement damage. J. Immunol. 152, 2952-2959.
46. Schindler, C., Darnell, J. E. (1995) Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64, 621-651.
47. Biron, C. A. (1994) Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr. Op. Immunol. 6, 530-538.
48. McFadden, G., Graham, K., Ellison, K., Barry, M., Macen, J., Schreiber, M., Mossman, K., Nash, P., Lalani, A., Everett, H. (1995) Interruption of cytokine networks by poxviruses: lessons from myxoma virus. J. Leukoc. Biol. 57, 731-738.
49. Alcami, A., Smith, G. L. (1992) A soluble receptor for interleukin-1B encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71, 153-167.
50. Symons, J. A., Alcami, A., Smith, G. L. (1995) Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81, 551-560.
51. Colamonici, O. R., Domanski, P., Sweitzer, S. M., Larner, A., Buller, R. M. L. (1995) Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signalling. J. Biol. Chem. 270, 15974-15978.
52. Upton, C., Mossman, K., McFadden, G. (1992) Encoding of a homolog of the IFN-γ receptor by myxoma virus. Science 258, 1369-1372.
53. Ahuja, S. K., Gao, J. L., Murphy, P. M. (1994) Chemokine receptors and molecular mimicry. Immunol. Today 15, 281-287.
54. Hsu, D., De Waal Malefyt, R., Florentino, D. F., Dang, M., Vieira, P., De-Vries, J., Spits, H., Mosmann, T. R., Moore, K. W. (1990) Expression of Interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250, 830-832.
55. Moore, K. W., O'Garra, A., De Waal Malefyt, R., Vieira, V., Mosmann, T. R. (1993) Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. Annu. Rev. Immunol. 11, 165-190.
56. Wold, W. S. M., Hermiston, T. W., Tollefson, A. E. (1994) Adenovirus proteins that subvert host defenses. Trends Microbiol. 2, 437-443.
57. Gale, M., Tan, S. L., Wambach, M., Katze, M. G. (1996) Interaction of the interferon-induced PKR protein kinase with inhibitory proteins P58IPK and vaccinia virus K3L is mediated by unique domains: implication for kinase regulation. Mol. Cell. Biol. 16, 4172-4181.
58. Ho, C. K., Shuman, S. (1996) Mutational analysis of the vaccinia virus E3 protein defines amino acid residues involved in E3 binding to double-stranded RNA. J. Virol. 70, 2611-2614.
59. Kotwal, G. J., Blasco, R., Miller, C. G., Kuntz, S., Jayaraman, S., Shchelkunov, S. N. (1998) Strategies for immunomodulation and evasion by microbes: important consideration in the development of live vaccines. In Symposium on Immunology VII. Berlin: Springer Verlag, in press.
60. Beusher, H. U., Rodel, F., Forsberg, A., Rollinghoff, M. (1995) Bacterial evasion of host immune defense: Yersinia enterocolitica encodes a suppressor for tumor necrosis factor alpha expression. Infect. Immun. 63, 1270-1277.
61. Teodoro, J. E., Branton, P. E. (1997) Regulation of apoptosis by viral gene products. J. Virol. 71, 1739-1746.
62. Krajcsi, P., Dimitrov, T., Hermiston, T. W., Tollefson, A. E., Ranheim, T. S., Vande Pol, S. B., Stephenson, A. H., Wold, W. S. M. (1996) The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid. J. Virol. 70, 4904-4913.
63. Tewari, M., Telford, W. G., Miller, R. A., Dixit, V. M. (1995) CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J. Biol. Chem. 270, 22705-22708.
64. Banks, T. A., Rouse, B. T. (1992) Herpesviruses - immune escape artists? Clin. Infect. Dis. 14, 933-941.
65. Germain, R. N. (1995) MHC-associated antigen processing, presentation, and recognition: Adolescence, maturity, and beyond. Immunologist 3, 185-190.
66. Spriggs, M. K., Armitage, R. J., Comeau, M. R., Strockbine, L., Farrah, T., McDuf, B., Ulrich, D., Alderson, M. R., Mullberg, J., Cohen, J. I. (1996) The extracellular domain of the Epstein-Barr Virus BZLF2 protein binds the HLA-DR β chain and inhibits antigen presentation. J. Virol. 70, 5557-5563.
67. Brutkiewicz, R. R., Welsh, R. M. (1995) Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J. Virol. 69, 3967-3971.
68. Fruh, K., Ahn, K., Djaballah, H., Sempe, P., Van Endert, P. M., Tampe, R., Peterson, P. A., Yang, Y. (1995) A viral inhibitor of peptide transporters for antigen presentation. Nature 375, 415-418.
69. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H., Johnson, D. (1995) Herpes simplex virus turns off the TAP to evade host immunity. Nature 375, 411-415.
70. Wiertz, E. J. H. J., Jones, T. R., Sun, L., Bogyo, M., Geuze, H. J., Ploegh, H. L. (1996) The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84, 769-777.
71. Kotwal, G. J., Moss, B. (1988) Analysis of a large cluster of nonessential genes deleted from a vaccinia virus terminal transposition mutant. Virology 167, 524-537.
72. Oldstone, M. B. A. (1987) Molecular mimicry and autoimmunity. Cell 50, 819-820.
73. Wucherpfennig, K. W., Strominger, J. L. (1995) Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 80, 695-705.
74. Adams, G., Kuntz, S., Rabalais, G., Bratcher, D., Tamburro, C. H., Kotwal, G. J. (1997) Natural recovery from acute hepatitis C virus infection by agammaglobulinemic twin children. Ped. Infect. Dis. J. 16, 533-534.
75. Moore, P. S., Boshoff, C., Weiss, R. A., Chang, Y. (1996) Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274, 1739-1744.
76. Senkevich, T. G., Bugert, J. J., Sisler, J. R., Koonin, E. V., Darai, G., Moss, B. (1996) Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science 273, 813-816.
77. Feng, Y., Broder, C. C., Kennedy, P. E., Berger, E. A. (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
78. Alkhatrib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., Berger, E. A. (1996) CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958.
79. Dorig, R. E., Marcil, A., Chopra, A., Richardson, C. D. (1993) The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295-305.
80. Karnauchow, T. M., Tolson, D. L., Harrison, B. A., Altman, E., Lublin, D. M., Dimock, K. (1996) The HeLa cell receptor for Enterovius 70 is decay-accelerating factor (CD55). J. Virol. 70, 5143-5152.
81. Tanner, J., Weis, J., Fearon, D., Whang, Y., Kieff, E. (1987) Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell 50, 203-213.
82. Nemerow, G. R., Houghten, R. A., Moore, M. D., Cooper, N. R. (1989) Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor. Cell 56, 369-377.
83. Katz, E., Wolffe, E. J., Moss, B. (1997) The cytoplasmic and transmembrane domains of vaccinia virus BSR protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions. J. Virol. 71, 3178-3187.
84. Okada, N., Liszewski, M. K., Atkinson, J. P., Caparon, M. (1995) Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group a streptococcus. Proc. Natl. Acad. Sci. USA 92, 2489-2493.
85. 4. Implications for the pathogenesis of rheumatoid arthritis. J. Immunol. 155, 5057-5063.
86. Serhir, B., Higgins, R., Foiry, B., Jacques, M. (1993) Detection of immunoglobulin-G-binding proteins in Streptococcus suis. J. Gen. Microbiol. 139, 2953-2958.
87. Rizvi, F. S., Ouaissi, M. A., Marty, B., Santoro, F., Capron, A. (1988) The major surface protein of Leishmania promastigotes is a fibronectin-like molecule. Eur. J. Immunol. 18, 473-476.
88. Wilson, M. E., Pearson, R. D. (1988) Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes. Infect. Immun. 56, 363-369.
89. Silva, E. E., Clarke, M. W., Podesta, R. B. (1993) Characterization of a C3 receptor on the envelope of Schistosoma mansoni. J. Immunol. 151, 7057-7066.
90. Haynes, J. D., Dalton, J. P., Klotz, F. W., McGinniss, M. H., Hadley, T. J., Hudson, D. E., Miller, L. H. (1988) Receptor-like specificity of a Plasmodium knowlesi malarial protein that binds to Duffy antigen ligands on erythrocytes. J. Exp. Med. 167, 1873-1881.